about
Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation.A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma.Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling.Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.Cyclosporin in steroid-resistant autoimmune hepatitis and HCV-related liver diseases.Feasibility and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) in children.Monogenic diseases that can be cured by liver transplantation.Technical aspects of intestinal transplantation.Is there a role for high dose chemotherapy and blood stem cell rescue in childhood hepatoblastoma presenting with lung metastases? A case report and literature review.Risk-adapted Treatment for Severe B-Lineage Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation in Children.Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.Liver transplantation for adenomatosis: European experience.Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry.Urgent lung transplant programme in Italy: analysis of the first 14 months.A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study.Transplantation for acute liver failure in children.Hepatitis C virus genotypes and reinfection of the graft during long-term follow-up in 35 liver transplant recipients.Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient.Milan multicenter experience in 96 liver transplants for hepatitis B virus-related cirrhosis.A cause of late graft dysfunction after liver transplantation in children: de-novo autoimmune hepatitis.Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus.Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis.[Bench surgery in orthotopic liver transplantation. The authors' personal experience]Results in 50 orthotopic liver transplants in Milan.Liver perfusion in multiorgan harvesting for transplantation.On-line monitoring of lung mechanics during spontaneous breathing: a physiological study.Circulating Epstein-Barr virus DNA to monitor lymphoproliferative disease following pediatric liver transplantation.Hepatitis C virus infection in liver allograft recipients.Hepatitis C virus infection and liver transplantation.Does the experience with liver transplantation suggest that hepatitis delta virus is not cytopathic?Prevention of hepatitis B virus reinfection after liver transplantation.Surgical gene therapy by domino auxiliary liver transplantation.Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation.Alternative split liver technique: the equal size split.Predictive value of nodule size and differentiation in HCC recurrence after liver transplantation.The impact of perioperative transfusion of blood products on survival after pediatric liver transplantation.Early detection of the graft failure after pediatric liver transplantation: a Bergamo experience.Pretransplant management of basilar artery aneurysm and moyamoya disease in a child with Alagille syndrome.
P50
Q33365746-6703D342-6F5B-4063-9D69-8FA413516162Q33575450-C48C34E3-6DD9-4742-A665-E6BB04DB462EQ35915987-1175B753-9245-42E0-B285-C32C32900E5BQ36381360-D59768F1-7CD8-4316-B4DE-113F80EC5305Q37026288-02EB5D9D-7705-437A-9BBD-DF101864AEE6Q37974106-80899026-E612-4E2E-A6C5-E6D663836C17Q38098339-27FB5023-EB05-4DAB-B3FF-441628E32313Q38105867-33298A4F-FE10-4FA2-99AE-642F3EACFB3BQ38154738-5BD26F4B-D0A1-4A52-8356-FFF79908A4E9Q38565961-F17F3322-302B-429D-B43E-093CFAD4773DQ39179249-5AF6D5B1-8918-4431-9E3F-E2CF4F44053BQ39965786-6EB878F5-D056-4925-BEDF-1345C427D645Q41373558-D7414706-A473-48C9-9A12-884F2099179CQ41960217-AAF06ECE-DE0C-4656-BFD0-1DF3BB323C73Q42259673-F7B4F866-A731-495E-99DE-49C50808F34FQ42637095-79B2959B-EF2D-4F60-8E18-B0EB2CA7A8F1Q42654367-FE687AB5-A061-41D8-A200-D7DD1915D65AQ42980609-AF30B468-D821-44C9-A1B2-5A054DE50B71Q43035343-CA2BA45F-86BC-4CC3-BB4A-EDB2941B9580Q43042030-2D6C52DD-7F63-48B2-816D-9B0E72B817A8Q43553147-E7C2F022-8AF0-409D-8417-AD121E7D6B4EQ43843530-F7BA22C6-05B5-4F2B-BEA1-B0C935E1F1F7Q44101766-A73534E8-AB13-4687-9F43-99A624D2573AQ44204150-E773D518-D630-4408-B40F-BDE899009431Q44812338-D5609B84-3846-499B-B383-ECE509E98FEDQ44816716-07B0779A-D9E2-4F0F-A957-C00CE66FCAF7Q44835841-DDCB42C1-384D-4137-A3B1-2E5CC1C4EBE4Q45148070-5D3E4176-3A38-4CE7-8454-5209B9A153A0Q45739439-8E9424DB-F799-4926-A4B4-A9C729DC7FA3Q45790112-5D059CCD-3BE0-4CEF-AD4B-3A043558CCB8Q45844522-F7EA8B54-570C-4333-818E-33CDBF308B3DQ45848873-DEFE2B9D-3757-42CE-8820-02BDB8640058Q45852582-9B60611C-0B18-47D3-8F1D-6B3D54E7350FQ45878979-D6CD8244-4065-4A05-B89E-99FDD2EBEDDAQ46185590-89B84315-74C6-4315-A8C6-39F865D30585Q47215831-66471A6E-0F5E-4C28-ABF9-F9C706385184Q47359497-3FB01C3D-7E51-407E-BCCB-17E623564687Q48177340-A0467FC1-E95F-4D01-8B0B-33FDCB89CA29Q48256660-CD03366B-F27F-4917-93BD-857443609268Q48606049-006C64F4-CA39-4309-891E-594B057E0820
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michele Colledan
@ast
Michele Colledan
@en
Michele Colledan
@es
Michele Colledan
@nl
Michele Colledan
@sl
type
label
Michele Colledan
@ast
Michele Colledan
@en
Michele Colledan
@es
Michele Colledan
@nl
Michele Colledan
@sl
prefLabel
Michele Colledan
@ast
Michele Colledan
@en
Michele Colledan
@es
Michele Colledan
@nl
Michele Colledan
@sl
P1053
O-9938-2016
P106
P31
P3829
P496
0000-0002-3880-4763